glp 1 nom commercial Ro | Serena On Ro Novo Nordisk slammed with another

While originally approved for type 2 diabetes and cardiovascular disease, these drugs have demonstrated significant efficacy for weight loss, fueling public demand and legislative proposals to expand coverage

Others, like tirzepatide, which is one of the newest ones, it acts on the GLP-1 receptor and another hormone pathway called GIP

Studies show that GLP-1 medications can impact gastric motility, which can contribute to symptoms like bloating and side effects like sulfur burps, especially in people who are sensitive to changes in their digestion

Balanced meals, activity, hydration, and sleep consistency support better outcomes

Conclusions GLP-1 receptor agonists are useful drugs for the treatment of patients with T2D